MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Comparison of cognitive and neuropsychological manifestations in patients with progressive supranuclear palsy (Psp) and Parkinson’s disease

M.U. Kulsum, S.S. Anand, S. Chatterjee, P. Chatterjee, B. Mondal, S. Choudhury, K. Chatterjee, R. Banerjee, S.S. Jha, H. Kumar (Kolkata, India)

Meeting: 2016 International Congress

Abstract Number: 146

Keywords: Cognitive dysfunction, Dementia, Parkinsonism, Progressive supranuclear palsy(PSP)

Session Information

Date: Monday, June 20, 2016

Session Title: Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: 1) To compare the cognitive and neuropsychological manifestations between the patients with PSP and PD. 2) To find out the severity of caregivers distress of the patients with PSP and PD.

Background: Progressive Supranuclear Palsy (PSP) and Parkinson’s disease (PD) have distinct motor features. But difference in cognitive and behavioral symptoms between the two has been less well studied.

Methods: 25 patients with PSP diagnosed on the basis of National Institute of Neurological Disorder and Stroke-Progressive Supranuclear Palsy (NINDS- PSP) criteria, and 25 patients with PD diagnosed on the basis of UK Parkinson’s disease Society Brain Bank Criteria were assessed on socio demographic and clinical profile. Motor examination was done using Unified Parkinson’s disease Rating Scale (UPDRS) III. Cognitive screening was done using Mini Mental State Examination. Cognitive profile and severity of cognitive impairment was assessed using Mattis Dementia Rating Scale (DRS). Neuropsychiatric Inventory was used to find out the neuropsychological manifestations and the severity of the caregiver’s distress.

Results: According to Mattis DRS, 13 (52%) patients with PSP and 9 (36%) patients with PD had severe cognitive impairment. There was trend of lower mean value on Mattis DRS in patients with PSP as compared to PD in the domain like attention(32.8, 33.88), IP(27.68, 29.24), Construction(3.48,4.72), Conceptualization (29,28.92), Memory (17.88,18.08). Among neuropsychological symptoms hallucination was more frequent in patient with PD (PD- 64%, PSP-16%, p 0.001) whereas, apathy was more common in PSP patients (PSP-68%, PD-44%, p 0.08). According to NPI, aggression was responsible for moderate to severe caregiver distress in 12 PSP patients and 4 PD patients. Similar values for hallucination was 6(PSP) and 5(PD), disinhibition was 6 (PSP) and 5 (PD) whereas, delusion was 3 (PSP) and 7 (PD).

Conclusions: The cognitive and neuropsychological symptoms were worse in patients with PSP as compared to that in PD. Aggression, hallucination, disinhibition and delusion had more bearing on caregiver’s distress.

To cite this abstract in AMA style:

M.U. Kulsum, S.S. Anand, S. Chatterjee, P. Chatterjee, B. Mondal, S. Choudhury, K. Chatterjee, R. Banerjee, S.S. Jha, H. Kumar. Comparison of cognitive and neuropsychological manifestations in patients with progressive supranuclear palsy (Psp) and Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/comparison-of-cognitive-and-neuropsychological-manifestations-in-patients-with-progressive-supranuclear-palsy-psp-and-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/comparison-of-cognitive-and-neuropsychological-manifestations-in-patients-with-progressive-supranuclear-palsy-psp-and-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley